X-153954909-A-G
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_005334.3(HCFC1):āc.3490T>Cā(p.Ser1164Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,169,617 control chromosomes in the GnomAD database, including 37,426 homozygotes. There are 97,476 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_005334.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HCFC1 | NM_005334.3 | c.3490T>C | p.Ser1164Pro | missense_variant | 17/26 | ENST00000310441.12 | NP_005325.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HCFC1 | ENST00000310441.12 | c.3490T>C | p.Ser1164Pro | missense_variant | 17/26 | 1 | NM_005334.3 | ENSP00000309555.7 | ||
HCFC1 | ENST00000369984.4 | c.3490T>C | p.Ser1164Pro | missense_variant | 17/26 | 5 | ENSP00000359001.4 |
Frequencies
GnomAD3 genomes AF: 0.383 AC: 42496AN: 111025Hom.: 7962 Cov.: 24 AF XY: 0.386 AC XY: 12865AN XY: 33317
GnomAD3 exomes AF: 0.387 AC: 46926AN: 121239Hom.: 9248 AF XY: 0.379 AC XY: 12732AN XY: 33571
GnomAD4 exome AF: 0.239 AC: 252780AN: 1058535Hom.: 29455 Cov.: 34 AF XY: 0.247 AC XY: 84564AN XY: 341803
GnomAD4 genome AF: 0.383 AC: 42556AN: 111082Hom.: 7971 Cov.: 24 AF XY: 0.387 AC XY: 12912AN XY: 33384
ClinVar
Submissions by phenotype
not specified Benign:3
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 31, 2016 | - - |
Methylmalonic acidemia with homocystinuria, type cblX Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at